Stock CONTRAVIR PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News ContraVir Pharmaceuticals Inc OTC Bulletin Board

Equities

US21234W1036

End-of-day quote OTC Bulletin Board
Other stock markets
- USD - Intraday chart for ContraVir Pharmaceuticals Inc
05-21 Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-22 Sector Update: Health Care Stocks Increase Late Afternoon MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hepion Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Sector Update: Health Care Stocks Increase Late Afternoon
MT
Sector Update: Health Care
MT
Top Midday Decliners
MT
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial
AQ
North American Morning Briefing: Stock Futures Rise, Busy Week of Earnings Ahead
DJ
Hepion Pharmaceuticals Starts Wind-Down Activities in Phase 2b ASCEND-NASH Trial
MT
Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
AQ
Hepion Pharmaceuticals, Inc. Initiates Wind-Down Activities in Phase 2b ?ASCEND-NASH? Trial
CI
Hepion Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Hepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
AQ
Hepion Pharmaceuticals, Inc. Appoints Michael Purcell to Its Board of Directors
CI
Hepion Pharmaceuticals, Inc. Announces Board Changes
CI
Hepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
AQ
Hepion Pharmaceuticals, Inc. Announces Resignation of Anand Reddi from the Board of Directors
CI
Hepion Pharmaceuticals to Present at NASH-TAG 2024
AQ
North American Morning Briefing : Futures Pause -2-
DJ
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value
CI
Hepion Pharmaceuticals Approves Restructuring Plan to Preserve Capital, Launches Strategic Review Process
MT
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HEPA Stock
  4. Stock
  5. News ContraVir Pharmaceuticals Inc